Formosa Chemicals & Fibre (1326) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
29 May, 2026Executive summary
Audit confirms fair presentation of consolidated financial statements for 2024 and 2023 in accordance with IFRS and local regulations.
Key audit matters include loss allowance for accounts receivable and inventory valuation due to significant management judgment and market volatility.
Several subsidiaries and associates contribute materially to assets and comprehensive income.
Financial highlights
Operating revenue for 2024 was NT$348.6 billion, up 5% year-over-year.
Net income for 2024 was NT$1.12 billion, a sharp decline from NT$7.7 billion in 2023.
Total comprehensive loss for 2024 was NT$69.05 billion, compared to a gain of NT$18.07 billion in 2023, mainly due to unrealized losses on financial assets.
Basic EPS for 2024 was NT$0.19, down from NT$1.32 in 2023.
Total assets at year-end 2024 were NT$490.95 billion, down from NT$565.87 billion in 2023.
Outlook and guidance
New standards effective in 2025 and beyond are not expected to have significant impact.
Board approved a cash dividend of NT$0.50 per share for 2024.
Latest events from Formosa Chemicals & Fibre
- Q1 2024 returned to profit, but large unrealized investment losses led to a comprehensive loss.1326
Q1 202429 May 2026 - Net income fell sharply despite higher revenue, with a NT$33.7 billion comprehensive loss.1326
Q3 202429 May 2026 - Net income surged to NT$3.47B on 14% revenue growth, despite investment losses.1326
Q2 202429 May 2026 - Q1 2025 posted a net loss and revenue decline, with a qualified audit opinion and higher leverage.1326
Q1 202529 May 2026 - H1 2025 saw a net loss, negative EPS, and broad segment underperformance amid market challenges.1326
Q2 202529 May 2026 - Nine-month net loss of NT$5.5 billion on revenue of NT$222.0 billion, with all segments in deficit.1326
Q3 202529 May 2026 - 2025 saw a net loss and revenue drop, but a NT$0.60 dividend was approved.1326
Q4 202529 May 2026 - Q1 115 delivered strong profit recovery, improved margins, and robust investment income.1326
Q1 202629 May 2026